In vitro activities of the new ketolide HMR 3647 (telithromycin) in comparison with those of eight other antibiotics against viridans group streptococci isolated from blood of neutropenic patients with cancer

被引：21

作者：

Alcaide, F

Benítez, MA

Carratalà, J

Gudiol, F

Liñares, J

Martín, R

机构：

[1] Ciutat Sanitaria & Univ Bellvitge, Hosp Princeps Espanya, Microbiol Serv, Dept Microbiol, Barcelona 08907, Spain

[2] Ciutat Sanitaria & Univ Bellvitge, Hosp Princeps Espanya, Dept Infect Dis, Barcelona 08907, Spain

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2001年 / 45卷 / 02期

关键词：

D O I：

10.1128/AAC.45.2.624-626.2001

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The in vitro activities of the ketolide telithromycin and eight other antibiotics were tested against 77 strains of viridans group streptococci isolated from blood samples of neutropenic patients. Thirty-one (40.3%) of the strains were resistant to penicillin G, and 27 (35.1%) were resistant to erythromycin A. Telithromycin (MIC range of less than or equal to0.03 to 1 mug/ml) was the most active antimicrobial tested. These data suggest that telithromycin could be useful for treatment of viridans group streptococcal bacteremia in neutropenic patients with cancer.

引用

页码：624 / 626

页数：3

共 30 条

[1] In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients [J].

Alcaide, F ;

Carratala, J ;

Linares, J ;

Gudiol, F ;

Martin, R .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (09) :2117-2120

[2] IN-VITRO ACTIVITIES OF 22-BETA-LACTAM ANTIBIOTICS AGAINST PENICILLIN-RESISTANT AND PENICILLIN-SUSCEPTIBLE VIRIDANS GROUP STREPTOCOCCI ISOLATED FROM BLOOD [J].

ALCAIDE, F ;

LINARES, J ;

PALLARES, R ;

CARRATALA, J ;

BENITEZ, MA ;

GUDIOL, F ;

MARTIN, R .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (10) :2243-2247

[3]

[Anonymous], 1999, M100S9 NAT COMM CLIN

[4] STREPTOCOCCAL AND ENTEROCOCCAL BACTEREMIA IN PATIENTS WITH CANCER [J].

AWADA, A ;

VANDERAUWERA, P ;

MEUNIER, F ;

DANEAU, D ;

KLASTERSKY, J .

CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) :33-48

[5] In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae [J].

Barry, AL ;

Fuchs, PC ;

Brown, SD .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :2138-2140

[6] Streptococcus viridans bacteremia following autologous peripheral blood stem cell transplantation [J].

Bilgrami, S ;

Feingold, JM ;

Dorsky, D ;

Edwards, RL ;

Clive, J ;

Tutschka, PJ .

BONE MARROW TRANSPLANTATION, 1998, 21 (06) :591-595

[7] BACTEREMIA DUE TO VIRIDANS STREPTOCOCCI IN NEUTROPENIC PATIENTS - A REVIEW [J].

BOCHUD, PY ;

CALANDRA, T ;

FRANCIOLI, P .

AMERICAN JOURNAL OF MEDICINE, 1994, 97 (03) :256-264

[8] BACTEREMIA DUE TO VIRIDANS STREPTOCOCCUS IN NEUTROPENIC PATIENTS WITH CANCER - CLINICAL SPECTRUM AND RISK-FACTORS [J].

BOCHUD, PY ;

EGGIMAN, P ;

CALANDRA, T ;

VANMELLE, G ;

SAGHAFI, L ;

FRANCIOLI, P .

CLINICAL INFECTIOUS DISEASES, 1994, 18 (01) :25-31

[9] Nomenclature for aerobic and facultative bacteria [J].

Bruckner, DA ;

Colonna, P .

CLINICAL INFECTIOUS DISEASES, 1997, 25 (01) :1-10

[10] BACTEREMIA DUE TO VIRIDANS STREPTOCOCCI THAT ARE HIGHLY RESISTANT TO PENICILLIN - INCREASE AMONG NEUTROPENIC PATIENTS WITH CANCER [J].

CARRATALA, J ;

ALCAIDE, F ;

FERNANDEZSEVILLA, A ;

CORBELLA, X ;

LINARES, J ;

GUDIOL, F .

CLINICAL INFECTIOUS DISEASES, 1995, 20 (05) :1169-1173

← 1 2 3 →